Vg Life Sciences Stock Fundamentals

VGLS Stock  USD 0.0001  0.00  0.00%   
Vg Life Sciences fundamentals help investors to digest information that contributes to Vg Life's financial success or failures. It also enables traders to predict the movement of VGLS Pink Sheet. The fundamental analysis module provides a way to measure Vg Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vg Life pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Vg Life Sciences Company Return On Asset Analysis

Vg Life's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Vg Life Return On Asset

    
  -1.51  
Most of Vg Life's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vg Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Vg Life Sciences has a Return On Asset of -1.5118. This is 82.72% lower than that of the Biotechnology sector and 93.59% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.

Vg Life Sciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Vg Life's current stock value. Our valuation model uses many indicators to compare Vg Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vg Life competition to find correlations between indicators driving Vg Life's intrinsic value. More Info.
Vg Life Sciences is rated below average in return on asset category among its peers. It is rated first in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vg Life's earnings, one of the primary drivers of an investment's value.

VGLS Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vg Life's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Vg Life could also be used in its relative valuation, which is a method of valuing Vg Life by comparing valuation metrics of similar companies.
Vg Life is currently under evaluation in return on asset category among its peers.

VGLS Fundamentals

About Vg Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Vg Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vg Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vg Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd. VG Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for VGLS Pink Sheet Analysis

When running Vg Life's price analysis, check to measure Vg Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vg Life is operating at the current time. Most of Vg Life's value examination focuses on studying past and present price action to predict the probability of Vg Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vg Life's price. Additionally, you may evaluate how the addition of Vg Life to your portfolios can decrease your overall portfolio volatility.